Your browser doesn't support javascript.
loading
Fully integrated wearable microneedle biosensing platform for wide-range and real-time continuous glucose monitoring.
Li, Lei; Zhou, Yujie; Sun, Chenwei; Zhou, Zhengming; Zhang, Jieyu; Xu, Yuanyuan; Xiao, Xuanyu; Deng, Hui; Zhong, Yuting; Li, Guoyuan; Chen, Zhiyu; Deng, Wei; Hu, Xuefeng; Wang, Yunbing.
Affiliation
  • Li L; National Engineering Research Center for Biomaterials & College of Biomedical Engineering, Sichuan University, Chengdu, Sichuan, 610065, China.
  • Zhou Y; National Engineering Research Center for Biomaterials & College of Biomedical Engineering, Sichuan University, Chengdu, Sichuan, 610065, China.
  • Sun C; National Engineering Research Center for Biomaterials & College of Biomedical Engineering, Sichuan University, Chengdu, Sichuan, 610065, China.
  • Zhou Z; Department of Nutrition and Food Hygiene, West China School of Public Health & West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
  • Zhang J; National Engineering Research Center for Biomaterials & College of Biomedical Engineering, Sichuan University, Chengdu, Sichuan, 610065, China.
  • Xu Y; National Engineering Research Center for Biomaterials & College of Biomedical Engineering, Sichuan University, Chengdu, Sichuan, 610065, China.
  • Xiao X; National Engineering Research Center for Biomaterials & College of Biomedical Engineering, Sichuan University, Chengdu, Sichuan, 610065, China.
  • Deng H; West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, Sichuan, 610041, China.
  • Zhong Y; National Engineering Research Center for Biomaterials & College of Biomedical Engineering, Sichuan University, Chengdu, Sichuan, 610065, China.
  • Li G; National Engineering Research Center for Biomaterials & College of Biomedical Engineering, Sichuan University, Chengdu, Sichuan, 610065, China.
  • Chen Z; National Engineering Research Center for Biomaterials & College of Biomedical Engineering, Sichuan University, Chengdu, Sichuan, 610065, China.
  • Deng W; Department of Orthopedics Pidu District People's Hospital, The Third Affiliated Hospital of Chengdu Medical College Chengdu, Sichuan, 611730, China.
  • Hu X; West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, Sichuan, 610041, China. Electronic address: huxuefeng@scu.edu.cn.
  • Wang Y; National Engineering Research Center for Biomaterials & College of Biomedical Engineering, Sichuan University, Chengdu, Sichuan, 610065, China. Electronic address: yunbing.wang@scu.edu.cn.
Acta Biomater ; 175: 199-213, 2024 02.
Article de En | MEDLINE | ID: mdl-38160859
ABSTRACT
Wearable microneedle sensors for continuous glucose monitoring (CGM) have great potential for clinical impact by allowing access to large data sets to provide individualized treatment plans. To date, their development has been challenged by the accurate wide linear range tracking of interstitial fluid (ISF) glucose (Glu) levels. Here, we present a CGM platform consisting of a three-electrode microneedle electrochemical biosensor and a fully integrated radio-chemical analysis system. The long-term performance of the robust CGM on diabetic rats was achieved by electrodepositing Prussian blue (PB), and crosslinking glucose oxidase (GOx) and chitosan to form a 3D network using glutaraldehyde (GA). After redox by GOx, PB rapidly decomposes hydrogen peroxide and mediates charge transfer, while the 3D network and graphite powder provide enrichment and release sites for Glu and catalytic products, enabling a sensing range of 0.25-35 mM. Microneedle CGM has high sensitivity, good stability, and anti-interference ability. In diabetic rats, CGM can accurately monitor Glu levels in the ISF in real-time, which are highly consistent with levels measured by commercial Glu meters. These results indicate the feasibility and application prospects of the PB-based CGM for the clinical management of diabetes. STATEMENT OF

SIGNIFICANCE:

This study addresses the challenge of continuous glucose monitoring system design where the narrow linear range of sensing due to the miniaturization of sensors fails to meet the monitoring needs of clinical diabetic patients. This was achieved by utilizing a three-dimensional network of glutaraldehyde cross-linked glucose oxidase and chitosan. The unique topology of the 3D network provides a large number of sites for glucose enrichment and anchors the enzyme to the sensing medium and the conductive substrate through covalent bonding, successfully blocking the escape of the enzyme and the sensing medium and shortening the electron transfer and transmission path.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Techniques de biocapteur / Chitosane / Diabète expérimental / Dispositifs électroniques portables Limites: Animals / Humans Langue: En Journal: Acta Biomater Année: 2024 Type de document: Article Pays d'affiliation: Chine

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Techniques de biocapteur / Chitosane / Diabète expérimental / Dispositifs électroniques portables Limites: Animals / Humans Langue: En Journal: Acta Biomater Année: 2024 Type de document: Article Pays d'affiliation: Chine
...